Business Description
Medicus Pharma Ltd
NAICS : 325412
SIC : 3741
ISIN : CA58471K1030
Description
Medicus Pharma Ltd will carry on the business of pharmaceutical drug development focused initially on SkinJect. The objective of SkinJect is developing and commercializing novel microneedle arrays for the purpose of treating certain skin cancers, initially basal cell carcinoma.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.74 | |||||
| Equity-to-Asset | 0.43 | |||||
| Debt-to-Equity | 2.89 | |||||
| Debt-to-EBITDA | -0.38 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.94 | |||||
| 9-Day RSI | 42.22 | |||||
| 14-Day RSI | 40.27 | |||||
| 6-1 Month Momentum % | 214.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.74 | |||||
| Quick Ratio | 1.74 | |||||
| Cash Ratio | 1.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -1.89 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -453.12 | |||||
| ROIC % | -23.65 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 32.39 | |||||
| Price-to-Tangible-Book | 31 | |||||
| EV-to-EBIT | -4.67 | |||||
| EV-to-EBITDA | -4.67 | |||||
| EV-to-FCF | -6.82 | |||||
| Price-to-Net-Current-Asset-Value | 31 | |||||
| Price-to-Net-Cash | 43.4 | |||||
| Earnings Yield (Greenblatt) % | -21.41 | |||||
| FCF Yield % | -15.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medicus Pharma Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.567 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 40.27 | ||
| 14-Day ATR (C$) | 0.030635 | ||
| 20-Day SMA (C$) | 2.2145 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (C$) | 0.31 - 3.05 | ||
| Shares Outstanding (Mil) | 16.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medicus Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medicus Pharma Ltd Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medicus Pharma Ltd Frequently Asked Questions
What is Medicus Pharma Ltd(TSXV:MDCX)'s stock price today?
The current price of TSXV:MDCX is C$2.17. The 52 week high of TSXV:MDCX is C$3.05 and 52 week low is C$0.31.
When is next earnings date of Medicus Pharma Ltd(TSXV:MDCX)?
The next earnings date of Medicus Pharma Ltd(TSXV:MDCX) is .
Does Medicus Pharma Ltd(TSXV:MDCX) pay dividends? If so, how much?
Medicus Pharma Ltd(TSXV:MDCX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers